itraconazole has been researched along with Atypical Mycobacterial Infection, Disseminated in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chongtrakool, P; Jitmuang, A; Wongkamhla, T | 1 |
Ishiguro, T; Kagiyama, N; Kawabata, Y; Shimizu, Y; Sugita, Y; Takaku, Y; Takayanagi, N; Yanagisawa, T | 1 |
Boonsarngsuk, V; Eksombatchai, D; Kanoksil, W; Tantrakul, V | 1 |
Jeon, K; Jeong, BH; Koh, WJ; Lee, SY; Moon, SM; Park, HY | 1 |
Denning, DW; Lestner, JM | 1 |
Chang, SE; Choi, JH; Kim, JE; Kim, MN; Lee, MW; Moon, KC; Sung, H; Won, CH | 1 |
Ito, N; Kudo, S | 1 |
De Schepper, J; De Schutter, I; De Wachter, E; Malfroot, A; Vanbesien, J | 1 |
Barton, RC; Evans, EG; Hafeez, I; McWhinney, P; Muers, MF; Murphy, SA | 1 |
Alberico, G; Cotilli, G; Goitre, M; Puiatti, P; Salvai, M | 1 |
1 review(s) available for itraconazole and Atypical Mycobacterial Infection, Disseminated
Article | Year |
---|---|
Airway obstruction caused by penicilliosis: a case report and review of the literature.
Topics: Adult; Airway Obstruction; Amphotericin B; Bronchoscopy; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Lupus Erythematosus, Systemic; Male; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Penicillium | 2015 |
9 other study(ies) available for itraconazole and Atypical Mycobacterial Infection, Disseminated
Article | Year |
---|---|
A case report of Talaromyces marneffei Oro-pharyngo-laryngitis: a rare manifestation of Talaromycosis.
Topics: Amphotericin B; Antifungal Agents; Autoantibodies; Deoxycholic Acid; Drug Combinations; Female; Humans; Interferon-gamma; Itraconazole; Laryngitis; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Mycoses; Pharyngitis; Talaromyces; Thailand | 2019 |
Allergic bronchopulmonary aspergillosis with repeated isolation of nontuberculous mycobacteria.
Topics: Adrenal Cortex Hormones; Aged; Aspergillosis, Allergic Bronchopulmonary; Diagnosis, Differential; Female; Humans; Itraconazole; Lung; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sputum; Thoracoscopy; Treatment Outcome | 2013 |
Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection.
Topics: Aged; Antibiotics, Antitubercular; Antifungal Agents; Coinfection; Female; Humans; Itraconazole; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pulmonary Aspergillosis; Retrospective Studies; Rifabutin; Rifampin | 2015 |
Tremor: a newly described adverse event with long-term itraconazole therapy.
Topics: Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Dose-Response Relationship, Drug; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pulmonary Aspergillosis; Tremor | 2010 |
Synchronous infection with Mycobacterium chelonae and Paecilomyces in a heart transplant patient.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Biopsy; Clarithromycin; Dermatomycoses; Drug Therapy, Combination; Heart Transplantation; Humans; Itraconazole; Leg; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Paecilomyces; Skin Diseases, Bacterial; Thumb | 2011 |
[Case of polycystic lung disease with mixed infections due to Aspergillus and Mycobacterium fortuitum successfully treated by AZM].
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azithromycin; Cysts; Drug Therapy, Combination; Humans; Itraconazole; Lung Diseases, Fungal; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Treatment Outcome; Tuberculosis, Pulmonary | 2002 |
Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bronchodilator Agents; Budesonide; Clarithromycin; Cushing Syndrome; Cystic Fibrosis; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Fatal Outcome; Female; Humans; Iatrogenic Disease; Infant, Newborn; Itraconazole; Lung Diseases; Male; Mycobacterium Infections, Nontuberculous | 2003 |
Non-tuberculous mycobacterial lung infection complicated by chronic necrotising pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Aspergillosis; Female; Humans; Itraconazole; Lung Diseases, Fungal; Lung Diseases, Obstructive; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Treatment Outcome | 2000 |
Sporotrichoid infection. Two cases.
Topics: Aged; Biopsy; Diagnosis, Differential; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Skin Diseases, Infectious; Sporothrix; Sporotrichosis | 1990 |